Neurobo Pharmaceuticals Inc (NRBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRBO | GOVX | KAPA | ||
| Company | Neurobo Pharmaceuticals Inc | Geovax Labs | Kairos Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 2.35 | 2.31 | 1.6900 | ||
| High | 2.44 | 2.38 | 1.7400 | ||
| Low | 2.32 | 2.19 | 1.5600 | ||
| Last | 2.36 | 2.29 | 1.5700 | ||
| Change | +0.01 | -0.03 | -0.1200 | ||
| % Change | +0.43% | -1.29% | -7.10% | ||
| Volume | 13,000 | 641,600 | 84,000 | ||
| 20-Day Average Volume | 35,165 | 721,215 | 92,775 | ||
| Previous Close | 2.35 | 2.32 | 1.6900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.50 | 2.47 | 1.6022 | ||
| 20-Day Raw Stochastic | 22.27% | 12.24% | 40.68% | ||
| 20-Day Relative Strength | 40.86% | 46.78% | 46.72% | ||
| Weighted Alpha | -57.49 | -87.97 | N/A | ||
| Today's Opinion | 100% Sell | 40% Sell | N/A | ||
| Previous Opinion | 100% Sell | 40% Sell | N/A | ||
| Last Month's Opinion | 88% Sell | 8% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.67% since 11/20/24 | -2.55% since 12/13/24 | -7.65% since 12/13/24 | ||
| Low | 2.30 on 11/26/24 | 2.17 on 12/17/24 | 1.5600 on 12/20/24 | ||
| High | 2.54 on 11/25/24 | 2.47 on 12/18/24 | 1.7800 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -15.11% since 10/25/24 | -12.26% since 11/20/24 | +7.53% since 11/20/24 | ||
| Low | 2.18 on 11/15/24 | 2.17 on 12/17/24 | 1.3300 on 12/09/24 | ||
| High | 3.00 on 10/28/24 | 3.15 on 11/25/24 | 1.9200 on 12/13/24 | ||
| 3-Month | |||||
| %Chg | -31.79% since 08/27/24 | -22.37% since 09/20/24 | -28.31% since 09/20/24 | ||
| Low | 2.08 on 10/10/24 | 1.75 on 11/04/24 | 1.2200 on 10/01/24 | ||
| High | 4.32 on 09/09/24 | 3.88 on 11/12/24 | 2.7500 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | -42.86% since 05/24/24 | +21.16% since 06/20/24 | N/A since 09/16/24 | ||
| Low | 2.08 on 10/10/24 | 1.60 on 08/08/24 | 1.2200 on 10/01/24 | ||
| High | 5.30 on 06/27/24 | 11.18 on 08/19/24 | 4.0000 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,334 | 21,609 | 20,170 | ||
| Shares Outstanding, K | 8,616 | 9,436 | 12,847 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -12,470,000 | -25,970,000 | -1,812,000 | ||
| Last Quarter Sales | 0 | 2,790,000 | 0 | ||
| Last Quarter Net Income | -5,650,000 | -5,820,000 | -1,047,000 | ||
| 60-Month Beta | -0.26 | 3.24 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/07/24 | -0.91 on 11/12/24 | -0.10 on 11/14/24 | ||
| Latest Earnings Date | 11/11/24 | 11/12/24 | 02/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||